Learn about 21 CFR Part 11, the FDA regulation ensuring the security, traceability, and compliance of electronic records and eSignatures in life sciences.
This white paper addresses the lack of regulatory guidelines for AI and introduces an interim path forward to realize the value of AI for life sciences organizations.
